Loading clinical trials...
Loading clinical trials...
The Effect of Implant Prosthesis Emergence Angle on Peri-Implant Health and Disease
The study was conducted at the Division of Periodontology, Bolu Abant İzzet Baysal University Faculty of Dentistry. Participants were systemically healthy individuals aged 18 to 70 who had received dental implant prostheses within the past five years and had high-quality panoramic radiographs. The peri-implant status of the subjects was evaluated using various indices and radiographic analyses in accordance with Chicago's Classification of Periodontal and Peri-Implant Diseases and Conditions. Additionally, measurements of gingival thickness, gingival phenotype, keratinized gingival width, and emergence angle were performed.
Patient histories were collected from those who met the study criteria, and panoramic radiographs were taken. A total of 310 implants were initially assessed, and 192 implants were selected for inclusion in the study. All implant patients underwent an evaluation of plaque index , gingival index, bleeding on probing , pocket depth, clinical attachment level, and gingival recession. The peri-implant condition was determined using these indices and radiographs, in accordance with the guidelines from the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions and the 2023 European Federation of Periodontology. Patients were categorized into three groups: peri-implantitis (64), peri-implant health (64), and peri-implant mucositis (64). Additionally, gingival thickness (GT), keratinized gingival width (KGW), and gingival phenotype (GP) around the implants were measured, and the emergence angle (EA) of the implants was calculated.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
Yes
Bolu Abant Izzet Baysal University, Dentistry Faculty
Bolu, Turkey (Türkiye)
Start Date
September 7, 2024
Primary Completion Date
April 30, 2025
Completion Date
May 1, 2025
Last Updated
December 22, 2025
192
ACTUAL participants
emergence profile
OTHER
Lead Sponsor
Abant Izzet Baysal University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07047261